This elevated TGFβ2 expression was also a reliable predictor of the presence of lymph node metastasis in GC patients, indicating that TGFβ2 may be a valuable prognostic indicator of metastatic progression in GC tumour types. Here, TGFB2 is linked to metastatic malignant neoplasm in the lymph nodes.